StockWatch
·
Major Chemicals
Quarterly ResultJul 29, 2026, 05:22 PM

Ingevity Q2 Adjusted EBITDA Up 14%; Raises Full-Year Outlook

AI Summary

Ingevity Corporation reported strong second-quarter 2026 financial results, with net income from continuing operations reaching $39.8 million and adjusted diluted EPS of $1.74. The company's adjusted EBITDA from continuing operations rose 14% to $115.0 million, driven by higher prices, favorable product mix, and increased volumes. Following these results, Ingevity raised its full-year 2026 Adjusted EBITDA outlook to a range of $380 million to $400 million and its diluted adjusted EPS outlook to $5.00 to $5.45. The company also completed the divestiture of its Road Markings product line for approximately $63 million in net proceeds.

Key Highlights

  • Net sales of $314.1 million, down 5% YoY; excluding Road Markings, sales increased 5%.
  • Net income from continuing operations was $39.8 million, or $1.13 per diluted share.
  • Adjusted diluted EPS from continuing operations was $1.74, up from $1.22 prior year.
  • Adjusted EBITDA from continuing operations increased 14% to $115.0 million.
  • Completed the sale of Road Markings product line on April 15, 2026, for approximately $63 million.
  • Raised full-year Adjusted EBITDA outlook to $380-$400 million.
  • Raised full-year diluted adjusted EPS outlook to $5.00-$5.45.
  • Repurchased approximately $35 million in shares at $70.94 per share.